Literature DB >> 29046482

Blunted rise in brain glucose levels during hyperglycemia in adults with obesity and T2DM.

Janice J Hwang1, Lihong Jiang2, Muhammad Hamza1, Elizabeth Sanchez Rangel1, Feng Dai3, Renata Belfort-DeAguiar1, Lisa Parikh1, Brian B Koo4, Douglas L Rothman2, Graeme Mason2, Robert S Sherwin1.   

Abstract

In rodent models, obesity and hyperglycemia alter cerebral glucose metabolism and glucose transport into the brain, resulting in disordered cerebral function as well as inappropriate responses to homeostatic and hedonic inputs. Whether similar findings are seen in the human brain remains unclear. In this study, 25 participants (9 healthy participants; 10 obese nondiabetic participants; and 6 poorly controlled, insulin- and metformin-treated type 2 diabetes mellitus (T2DM) participants) underwent 1H magnetic resonance spectroscopy scanning in the occipital lobe to measure the change in intracerebral glucose levels during a 2-hour hyperglycemic clamp (glucose ~220 mg/dl). The change in intracerebral glucose was significantly different across groups after controlling for age and sex, despite similar plasma glucose levels at baseline and during hyperglycemia. Compared with lean participants, brain glucose increments were lower in participants with obesity and T2DM. Furthermore, the change in brain glucose correlated inversely with plasma free fatty acid (FFA) levels during hyperglycemia. These data suggest that obesity and poorly controlled T2DM progressively diminish brain glucose responses to hyperglycemia, which has important implications for understanding not only the altered feeding behavior, but also the adverse neurocognitive consequences associated with obesity and T2DM.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29046482      PMCID: PMC5846903          DOI: 10.1172/jci.insight.95913

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  35 in total

1.  Central administration of oleic acid inhibits glucose production and food intake.

Authors:  Silvana Obici; Zhaohui Feng; Kimyata Morgan; Daniel Stein; George Karkanias; Luciano Rossetti
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

2.  Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy.

Authors:  Elizabeth R Seaquist; Ivan Tkac; Greg Damberg; William Thomas; Rolf Gruetter
Journal:  Metabolism       Date:  2005-08       Impact factor: 8.694

3.  The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans.

Authors:  E R Seaquist; G S Damberg; I Tkac; R Gruetter
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

4.  GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.

Authors:  Ethan A Winkler; Yoichiro Nishida; Abhay P Sagare; Sanket V Rege; Robert D Bell; David Perlmutter; Jesse D Sengillo; Sara Hillman; Pan Kong; Amy R Nelson; John S Sullivan; Zhen Zhao; Herbert J Meiselman; Rosalinda B Wendy; Jamie Soto; E Dale Abel; Jacob Makshanoff; Edward Zuniga; Darryl C De Vivo; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2015-03-02       Impact factor: 24.884

Review 5.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

6.  Differentiation of glucose transport in human brain gray and white matter.

Authors:  R A de Graaf; J W Pan; F Telang; J H Lee; P Brown; E J Novotny; H P Hetherington; D L Rothman
Journal:  J Cereb Blood Flow Metab       Date:  2001-05       Impact factor: 6.200

7.  No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.

Authors:  S G Hasselbalch; G M Knudsen; C Videbaek; L H Pinborg; J F Schmidt; S Holm; O B Paulson
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

Review 8.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

9.  Detection and assignment of the glucose signal in 1H NMR difference spectra of the human brain.

Authors:  R Gruetter; D L Rothman; E J Novotny; G I Shulman; J W Prichard; R G Shulman
Journal:  Magn Reson Med       Date:  1992-09       Impact factor: 4.668

10.  Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus.

Authors:  P J Boyle; S F Kempers; A M O'Connor; R J Nagy
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

View more
  27 in total

1.  Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine.

Authors:  Ochuko L Erukainure; Omamuyovwi M Ijomone; Olakunle Sanni; Michael Aschner; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

Review 2.  Revisiting How the Brain Senses Glucose-And Why.

Authors:  Marie Aare Bentsen; Zaman Mirzadeh; Michael W Schwartz
Journal:  Cell Metab       Date:  2018-12-06       Impact factor: 27.287

3.  Glycemic Variability and Brain Glucose Levels in Type 1 Diabetes.

Authors:  Janice J Hwang; Lihong Jiang; Elizabeth Sanchez Rangel; Xiaoning Fan; Yuyan Ding; Wai Lam; Jessica Leventhal; Feng Dai; Douglas L Rothman; Graeme F Mason; Robert S Sherwin
Journal:  Diabetes       Date:  2018-10-16       Impact factor: 9.461

4.  Metabolomic Assays of Postmortem Brain Extracts: Pitfalls in Extrapolation of Concentrations of Glucose and Amino Acids to Metabolic Dysregulation In Vivo in Neurological Diseases.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2018-08-16       Impact factor: 3.996

Review 5.  Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Authors:  Zaman Mirzadeh; Chelsea L Faber; Michael W Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2022-01-06       Impact factor: 13.820

6.  Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways.

Authors:  Prachya Kongtawelert; Chayanut Kaewmool; Thanyaluck Phitak; Mattabhorn Phimphilai; Peraphan Pothacharoen; Thuzar Hla Shwe
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

7.  Vernonia Amygdalina Del. stimulated glucose uptake in brain tissues enhances antioxidative activities; and modulates functional chemistry and dysregulated metabolic pathways.

Authors:  Ochuko L Erukainure; Olajumoke A Oyebode; Collins U Ibeji; Neil A Koorbanally; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-01-03       Impact factor: 3.584

8.  Humans with obesity have disordered brain responses to food images during physiological hyperglycemia.

Authors:  Renata Belfort-DeAguiar; Dongju Seo; Cheryl Lacadie; Sarita Naik; Christian Schmidt; Wai Lam; Janice Hwang; Todd Constable; Rajita Sinha; Robert S Sherwin
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-30       Impact factor: 4.310

9.  Personalized Dietary Management of Overweight and Obesity Based on Measures of Insulin and Glucose.

Authors:  Mads F Hjorth; Yishai Zohar; James O Hill; Arne Astrup
Journal:  Annu Rev Nutr       Date:  2018-06-01       Impact factor: 9.323

Review 10.  Glucose metabolic crosstalk and regulation in brain function and diseases.

Authors:  Shuai Zhang; Brittany Bolduc Lachance; Mark P Mattson; Xiaofeng Jia
Journal:  Prog Neurobiol       Date:  2021-06-10       Impact factor: 10.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.